Search by Drug Name or NDC

    NDC 51662-1213-01 25% Dextrose Infant 250 mg/mL Details

    25% Dextrose Infant 250 mg/mL

    25% Dextrose Infant is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by HF Acquisition Co. LLC, DBA Health First. The primary component is DEXTROSE MONOHYDRATE.

    Product Information

    NDC 51662-1213
    Product ID 51662-1213_ef6a78fb-553f-a83e-e053-2995a90a6164
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name 25% Dextrose Infant
    Proprietary Name Suffix n/a
    Non-Proprietary Name 25% Dextrose Infant
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 250
    Active Ingredient Units mg/mL
    Substance Name DEXTROSE MONOHYDRATE
    Labeler Name HF Acquisition Co. LLC, DBA Health First
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA019445
    Listing Certified Through 2024-12-31

    Package

    NDC 51662-1213-01 (51662121301)

    NDC Package Code 51662-1213-1
    Billing NDC 51662121301
    Package 1 SYRINGE, PLASTIC in 1 CARTON (51662-1213-1) / 10 mL in 1 SYRINGE, PLASTIC
    Marketing Start Date 2018-08-19
    NDC Exclude Flag N
    Pricing Information N/A